advertisement
11.4 Prostaglandins (28)
Showing records 1 to 25
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins10644 A comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in Europe
Garcia-Sanchez J; Rouland JF; Spiegel D; Pajic B; Cunliffe I; Traverso C; Landry J
British Journal of Ophthalmology 2004; 88: 877-83
10624 Effects of betaxolol and latanoprost on ocular blood flow and visual fields in patients with primary open-angle glaucoma
Erkin EF; Tarhan S; Kayikcioglu OR; Deveci H; Guler C; Goktan C
European Journal of Ophthalmology 2004; 14: 211-9
10859 Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: An eight-week, randomized, open-label, parallel-group, multicenter study in Latin America
Susanna Jr R; Sheu W-P
Clinical Therapeutics 2004; 26: 755-768
10534 Short-term effect of latanoprost on ocular circulation in ocular hypertension
Akarsu C; Bilgili YK; Taner P; Unal B; Ergin A
Clinical and Experimental Ophthalmology 2004; 32: 373-7
10536 A 5-year, multicenter, open-label, safety study of adjunctive latanoprost therapy for glaucoma
Alm A; Schoenfelder J; McDermott J
Archives of Ophthalmology 2004; 122: 957-65
10541 Long term effect of latanoprost on intraocular pressure in normal tension glaucoma
Ang A; Reddy MA; Shepstone L; Broadway DC
British Journal of Ophthalmology 2004; 88: 630-4
10543 Relation between axial length of the eye and hypotensive effect of latanoprost in primary open angle glaucoma
Arranz-Marquez E; Teus MA
British Journal of Ophthalmology 2004; 88: 635-7
10557 Trichiasis associated with prostaglandin analog use
Bearden W; Anderson R
Ophthalmic Plastic and Reconstructive Surgery 2004; 20: 320-2
10580 Cystoid macular edema in a low-risk patient after switching from latanoprost to bimatoprost
Carrillo MM; Nicolela MT
American Journal of Ophthalmology 2004; 137: 966-8
10586 Topical prostaglandin F2α analog induced poliosis
Chen CS; Wells J; Craig JE
American Journal of Ophthalmology 2004; 137: 965-6
10599 Effect of latanoprost on outflow facility in the mouse
Crowston JG; Aihara M; Lindsey JD; Weinreb RN
Investigative Ophthalmology and Visual Science 2004; 45: 2240-5
10610 Latanoprost exposure in pregnancy
De Santis M; Lucchese A; Carducci B; Cavaliere AF; De Santis L; Merola A; Straface G; Caruso A
American Journal of Ophthalmology 2004; 138: 305-6
10617 The influence of Latanoprost 0.005% on aqueous humor flow and outflow facility in glaucoma patients: a double-masked placebo-controlled clinical study
Dinslage S; Hueber A; Diestelhorst M; Krieglstein GK
Graefe's Archive for Clinical and Experimental Ophthalmology 2004; 242: 654-660
10621 Alkylphosphocholines: a new therapeutic option in glaucoma filtration surgery
Eibl KH; Banas B; Kook D; Ohlmann AV; Priglinger S; Kampik A; Welge-Luessen UC
Investigative Ophthalmology and Visual Science 2004; 45: 2619-24
10684 Switch to latanoprost monotherapy from combined treatment with beta-antagonist and other antiglaucoma agents in patients with glaucoma or ocular hypertension
Ito K; Goto R; Matsunaga K; Sugimoto K; Uji Y
Japanese Journal of Ophthalmology 2004; 48: 276-80
10685 Addition of topical bunazosin to latanoprost in multiple medical treatment for glaucoma
Iwakiri R; Kobayashi H; Kobayashi K; Okinami S
Japanese Journal of Clinical Ophthalmology 2004; 58: 359-362
10718 Safety and efficacy of unoprostone switched from latanoprost in patients with latanoprost-induced side effects
Kuga H; Miyauchi O; Fujimoto N; Sato E; Yamamoto S; Takeda N; Yamazaki H; Watanabe Y; Amaya K
Japanese Journal of Clinical Ophthalmology 2004; 58: 1187-1191
10725 Conjunctival hyperemia associated with bimatoprost use: A histopathologic study
Leal BC; Medeiros FA; Medeiros FW; Santo RM; Susanna R Jr.
American Journal of Ophthalmology 2004; 138: 310-3
10936 A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients
Manni G; Centofanti M; Parravano M; Oddone F; Bucci MG
Graefe's Archive for Clinical and Experimental Ophthalmology 2004; 6: Epub ahead of print
10750 Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism
Matias I; Chen J; De Petrocellis L; Bisogno T; Ligresti A; Fezza F; Krauss AH; Shi L; Protzman CE; Li C
Journal of Pharmacology and Experimental Therapeutics 2004; 309: 745-57
10751 Low incidence of iris pigmentation and eyelash changes in 2 randomized clinical trials with unoprostone isopropyl 0.15%
McCarey BE; Kapik BM; Kane FE; Unoprostone Monotherapy Study Group
Ophthalmology 2004; 111: 1480-8
10788 Comparison of latanoprost and dorzolamide in the treatment of patients with open angle glaucoma
Niazi MK; Raja N
Journal of Ayub Medical College Abbottabad: JAMC 2004; 16: 50-3
10799 The effect of substituting latanoprost 0.005% for unoprostone 0.12%
Otori Y; Tokugawa H; Morimura H; Okada M; Goto H; Miki A; Tano Y
Nippon Ganka Gakkai Zasshi 2004; 108: 207-12
10805 Latanoprost : an update of its use in glaucoma and ocular hypertension
Perry CM; McGavin JK; Culy CR; Ibbotson T
Drugs and Aging 2003; 20: 597-630
10816 Efficacy of Bimatoprost 0.03 Percent in Untreated Glaucoma and Ocular Hypertension Patients: Results from a Large Community-Based Clinical Trial
Quinones R; Severin T; Mundorf T
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 115-122
